6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
11m ago	Guggenheim Investments Announces May 2026 Closed-End Fund Distributions
12m ago	Blueport Acquisition Ltd and SingAuto Inc Announce Business Combination Agreement to Create a Publicly Listed Company
12m ago	MFS Government Markets Income Trust and MFS Intermediate Income Trust Announce Special Shareholder Meeting Relating to Proposed Appointment of Aberdeen Investments as Investment Adviser
12m ago	CCC Announces Extension of Private Placement of Units
13m ago	NATURAL GAS SERVICES GROUP, INC. REPORTS FIRST QUARTER 2026 FINANCIAL AND OPERATING RESULTS

About

Soligenix, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease

Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting

Recent Videos

Innovative Drug Development in Dermatology and Glioblastoma Treatment

Innovative Drug Development in Dermatology and Glioblastoma Treatment

Apr 14, 2026

Soligenix: Advancing HyBryte™ Toward Commercialization & Expanding Biotech Pipeline

Soligenix: Advancing HyBryte™ Toward Commercialization & Expanding Biotech Pipeline

Mar 31, 2026

Soligenix: Key Clinical Milestones Approach

Soligenix: Key Clinical Milestones Approach

Mar 25, 2026

BioMedWire Podcast Featuring Return of Dr. Christopher Schaber, CEO of Soligenix (NASDAQ: SNGX)

BioMedWire Podcast Featuring Return of Dr. Christopher Schaber, CEO of Soligenix (NASDAQ: SNGX)

Mar 19, 2026

Community Chat

Ask AI